Navigation Links
NewYork-Presbyterian/Weill Cornell physician-scientists present at 2010 American Urological Meeting
Date:6/2/2010

NEW YORK (May 29, 2010) -- Physician-scientists from NewYork-Presbyterian Hospital/Weill Cornell Medical Center will present their latest research findings at the American Urological Association's Annual Meeting in San Francisco, May 29 to June 3.

Dr. Steven Kaplan, a urologist and professor of urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and Dr. Darracott Vaughan, senior author and professor emeritus of urology at Weill Cornell Medical College, have published data showing that 5-alpha reductase inhibitors (5-ARI), drugs used to control for benign prostatic hypertrophy (BPH), an enlarged prostate, may greatly improve the accuracy of traditional PSA tests for prostate cancer diagnosis.

"Taking 5-ARI drugs may eliminate the background noise associated with PSA testing -- canceling out a benign response and leaving only one signal for malignancy," explains Dr. Kaplan, lead author of the study. "Using PSA testing, we may now be able to distinguish prostate cancer from benign prostatic hyperplasia (BPH) disease."

Dr. Kaplan will present these potentially groundbreaking findings during a press briefing on June 1 at 1:00 p.m. PST and for meeting attendees on June 2 at 12:20 p.m. PST at Moscone North, 120 & 123.

Among the most significant presentations are the following.

  • Surgeons' robotic surgery experience has impact on surgical cancer margins and operative time [2023] Wednesday, June 2, 1:00 p.m. 3:00 p.m.; Moscone North, 130 & 131

    Dr. Ashutosh Tewari
    Director of Robotic Prostatectomy and Prostate Cancer-Urologic Oncology Outcomes and Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Professor of Urology at Weill Cornell Medical College

    Dr. Tewari will present results from a multi-institutional study examining surgeons' robotic surgical experience. Recent media reports have raised concerns regarding training for robotic surgical procedures. The impact of experience is outlined in this study, demonstrating that greater surgical experience appears to be associated with a reduced percentage of positive surgical cancer margins and operative time after robot-assisted radical prostate removal.

  • Generic form of prostate enlargement drug shows fewer side effects [1786] Tuesday, June 1, 4:30 p.m. 4:40 p.m.; Moscone North, 120 & 123

    Dr. Alexis Te
    Director of the Brady Prostate Center and Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Professor of Urology at Weill Cornell Medical College

    Dr. Te will present results from a five-year study showing that generic, less-expensive drug for controlling prostate enlargement may produce fewer side-effects, such as erectile dysfunction, ejaculatory dysfunction, lowered libido and breast enlargement. The drugs 5alpha reductase inhibitors (5ARI) have been widely used in the management of men with benign prostatic hypertrophy (BPH). The study compared the generic finasteride and name brand dutasteride.

  • Fewer complications with laparoscopic kidney surgery compared with open [1482] Tuesday, June 1, 11:20 a.m. 11:30 a.m.; Moscone North, 122 & 125

    Dr. Douglas Scherr
    Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Associate Professor of Urology at Weill Cornell Medical College

    Dr. Scherr will present results showing that laparoscopic surgery has fewer complications than traditional open procedures for the treatment of kidney disease and cancer, such as lowered operative time during laparoscopic partial nephrectomy (LPN), less blood loss and shortened hospital stay.

  • New surgical modification for reduced incontinence following prostate removal [2029] Wednesday, June 2, 1:00 p.m. 3:00 p.m.; Moscone North, 130 & 131

    Dr. Ashutosh Tewari
    Director of Robotic Prostatectomy and Prostate Cancer-Urologic Oncology Outcomes and Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Professor of Urology at Weill Cornell Medical College

    Dr. Tewari will present findings showing that a surgical modification called the anatomic retro-apical technique reduces incontinence following robotic prostate removal surgery. Incontinence is the most common side effect following prostate removal.


'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Columbia University Medical Center
Source:Eurekalert

Related medicine news :

1. National Center on Minority Health and Health Disparities awards $8 million to Weill Cornell
2. iTriage Mobile Healthcare Technology Presented in Washington, DC at the Community Health Data Forum
3. TransforMED's Delta-Exchange Teams with Group Practice Forum to Present Free Webinar Series on Diabetes Population Management
4. RockWest Technology Group Presents Campus Contactless Card Technology at NACCU
5. Choosing Representation Can Help Disability Applicants Avoid Long Lines at Social Security Offices
6. Academic Impacts of Concussions for Students at Issue in House of Representatives
7. NextAid Presents BIDS BUILD HOPE Online Auction to Benefit Projects on the Ground in Africa on World AIDS Orphans Day
8. Harmony Information Systems Selected to Present at Exclusive MAVA Capital Connection 2010 Event
9. Morehead Presents Webinar on “Creating a High-Performing RN Workforce”
10. Meharry Medical College President Testifies Before the U.S. House of Representatives
11. PSA-TEC to Present State of the Industry Panel Discussion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Dickinson Insurance ... insurance and financial preparation services, is providing an update on a charitable event ... Rock City Rescue is a locally recognized nonprofit that provides shelter and care ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board ... Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will ... Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of President ...
(Date:10/13/2017)... , ... October 13, 2017 ... ... of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ... on guideline updates for the primary prevention of cardiovascular diseases during the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Global Healthcare ... scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare ... activity. The fun run is geared towards children of all ages; it is ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an update ... Puerto Rico , where the company manufactures ... Following a comprehensive onsite assessment, the ... temporary loss of power and minimal water damage due ... have resumed, and the company expects to return to ...
(Date:10/4/2017)... Korea , Oct. 4, 2017  South Korean-based ... next-generation CPR training aide "cprCUBE" on Kickstarter. The device ... compression during cardiac arrests with better efficiency compared to ... also offers real-time feedback on efficacy of the compression ... crowdfunding campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... Oct. 2, 2017  AllianceRx Walgreens Prime, the combined ... Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), ... which included the unveiling of new signage at its ... well as at a few other company-owned facilities across ... to patients, some of whom will begin to see ...
Breaking Medicine Technology: